Showing 1 posts of 1 posts found.
Cizzle Biotechnology has launched the commercial rollout of its CIZ1B Biomarker Blood Test for lung cancer in Texas in the …
Long-acting therapies set to reshape HIV treatment market
MHRA authorises Lynkuet for hot flushes linked to breast cancer therapy
MHRA approves Romvimza for tenosynovial giant cell tumour
NICE recommends allergy immunotherapy tablets for younger children
Dunbar Pharmaceuticals and IPS Pharma announce distribution agreement